Alembic Limited
ALEMBICLTD.BO- 1D
- -0.7%
Alembic Limited in brief
Alembic Limited is a listed company in the Pharmaceutical industry, based in India. It was founded in 1969. Its market value was $307 M on 19 November 2026, which makes it the 14,685th largest listed company in the world and the 1,085th largest in India on this site. In the year to Mar 2021 it had sales of $9 M and a net profit of $2 M, about 18 cents of profit for every dollar of sales.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Alembic Limited
Alembic Inc. is an American manufacturer of high-end electric basses, guitars and preamps. Founded in 1969, the company began manufacturing pre-amps before building complete instruments.
From Wikipedia: read the full article · text available under CC BY-SA 4.0
Alembic Limited timeline
- 1969
- 🏁
- 1999
- 📈Listed on National Stock Exchange of India as ALEMBICLTDFirst day of listing in the exchange's official list.
Events of Alembic Limited from Wikidata and the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Alembic Limited share price · NSE (ALEMBICLTD.NS)
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Nov 19, 2026 | 111.90 | 112.72 | 110.61 | 111.48 | -0.8% | 443,543 |
| Nov 18, 2026 | 113.78 | 114.88 | 112.00 | 112.41 | -1.2% | 543,434 |
| Nov 17, 2026 | 114.94 | 116.29 | 113.21 | 113.83 | -0.3% | 832,218 |
| Nov 16, 2026 | 113.82 | 116.49 | 111.92 | 114.19 | +0.6% | 1.4 M |
| Nov 13, 2026 | 112.50 | 118.23 | 112.50 | 113.47 | -0.7% | 2.8 M |
| Nov 12, 2026 | 116.00 | 117.20 | 113.00 | 114.28 | -1.2% | 2.3 M |
| Nov 11, 2026 | 106.41 | 116.49 | 105.52 | 115.67 | +8.5% | 8.8 M |
| Nov 9, 2026 | 99.00 | 114.38 | 99.00 | 106.58 | +5.3% | 30.2 M |
| Nov 6, 2026 | 96.70 | 104.40 | 95.10 | 101.22 | +3.5% | 2.0 M |
| Nov 5, 2026 | 97.80 | 99.49 | 96.21 | 97.82 | +3.3% | 868,666 |
| Nov 4, 2026 | 88.60 | 98.65 | 88.59 | 94.71 | +6.0% | 2.2 M |
| Nov 3, 2026 | 90.23 | 91.49 | 89.00 | 89.35 | -0.5% | 205,688 |
| Nov 2, 2026 | 87.22 | 90.38 | 87.06 | 89.80 | +3.0% | 233,182 |
| Oct 30, 2026 | 90.00 | 90.00 | 86.81 | 87.22 | -2.3% | 267,280 |
| Oct 29, 2026 | 87.00 | 89.49 | 86.86 | 89.31 | +2.0% | 269,681 |
| Oct 28, 2026 | 87.00 | 87.96 | 86.58 | 87.59 | +0.4% | 230,721 |
| Oct 27, 2026 | 85.50 | 87.88 | 84.45 | 87.22 | +3.0% | 328,926 |
| Oct 26, 2026 | 86.73 | 86.93 | 83.50 | 84.69 | -2.4% | 695,879 |
| Oct 23, 2026 | 90.78 | 90.78 | 86.04 | 86.73 | -3.9% | 629,663 |
| Oct 22, 2026 | 91.00 | 93.25 | 90.00 | 90.28 | -1.9% | 483,801 |
| Oct 21, 2026 | 95.50 | 96.10 | 91.52 | 92.00 | -3.3% | 473,990 |
| Oct 19, 2026 | 98.15 | 99.15 | 94.58 | 95.16 | -2.3% | 283,606 |
| Oct 16, 2026 | 95.90 | 98.16 | 95.69 | 97.36 | +1.3% | 230,343 |
| Oct 15, 2026 | 98.98 | 98.98 | 93.80 | 96.13 | -2.6% | 446,712 |
| Oct 14, 2026 | 98.00 | 99.50 | 97.56 | 98.68 | +0.4% | 298,032 |
| Oct 13, 2026 | 100.22 | 100.22 | 96.17 | 98.27 | -1.3% | 282,201 |
| Oct 12, 2026 | 100.14 | 101.00 | 98.35 | 99.56 | +0.3% | 324,821 |
| Oct 9, 2026 | 100.50 | 101.00 | 98.83 | 99.25 | -0.5% | 433,035 |
| Oct 8, 2026 | 103.39 | 103.48 | 99.01 | 99.72 | -3.7% | 602,964 |
| Oct 7, 2026 | 105.00 | 105.28 | 102.81 | 103.57 | — | 360,068 |
Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.
Alembic Limited share price statistics
Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.
Market cap history
World rank over time
Rank in India: #546 (Jan 2020) · #476 (Jan 2021) · #685 (Jan 2022) · #791 (Dec 2022) · #816 (Jul 2023) · #845 (Jan 2024) · #780 (Mar 2026) · #1,084 (Nov 2026) · #1,087 (Nov 2026) · #1,075 (Nov 2026) · #1,080 (Nov 2026) · #1,081 (Nov 2026) · #1,085 (Nov 2026)
Key ratios
- P/E ratio
- 181.6×
- Price / sales
- 32.3×
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- 17.8%
- Operating margin
- —
- Return on equity
- —
- Liabilities / assets
- —
Annual results
- Revenue
- $9 M
- Operating income
- —
- Net income
- $2 M
Mar-2021 ending year
Mutual funds holding Alembic Limited#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP | 639,254 | $1 M | — | <0.01% | −3.6% | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Value FundDimensional Fund Advisors LP | 360,019 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP | 269,593 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Global Ex-U.s. Real Estate Index FundThe Vanguard Group, Inc. | 263,179 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Avantis Emerging Markets Equity ETFAmerican Century ETF Trust | 146,783 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP | 101,475 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Core Equity Market ETFDimensional Fund Advisors LP | 69,654 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 61,733 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc. | 58,869 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Emerging Markets Social Core Equity PortfolioDimensional Fund Advisors LP | 38,303 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP | 28,091 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Value ETFDimensional Fund Advisors LP | 25,249 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 World ex U.S. Targeted Value PortfolioDimensional Fund Advisors LP | 15,848 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Avantis Emerging Markets Equity FundAmerican Century ETF Trust | 9,345 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Avantis Emerging Markets Small Cap Equity ETFAmerican Century ETF Trust | 4,513 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Avantis Emerging Markets ex-China Equity ETFAmerican Century ETF Trust | 633 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets ex China Core Equity ETFDimensional Fund Advisors LP | 284 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 17 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Where Alembic Limited operates: 2 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
How Alembic Limited compares in Pharmaceutical
- Market cap$307 M · higher than 28% of 393
- Revenue$9 M · higher than 7% of 324
- Net margin17.8% · higher than 79% of 313
- P/E ratio181.6× · lower than 4% of 172
- Price / sales32.3× · lower than 1% of 219
Peer comparison · Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Alembic Limited🇮🇳 | $307 M | 181.6× | 17.8% | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Amgen Inc.🇺🇸 | $249.2 B | 26.5× | 24.1% | +9.9% |
| AstraZeneca PLC🇬🇧 | $242.6 B | 23.7× | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
Sources and freshness
- Market cap:
- Nov 19, 2026
- Annual results:
- Mar-2021 ending year
- Balance sheet:
- Mar-2021 ending year
- Profile updated:
- Nov 20, 2026
Figures from Market data, value.today research, Wikidata, Wikipedia.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Alembic Limited? Verify and update this profile — free
Show Alembic Limited's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.